C1q-C Antibodies

Santa Cruz Biotechnology offers a broad range of C1q-C monoclonal antibodies for advanced research in immunology and related fields. C1q-C monoclonal antibodies are compatible with multiple experimental techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). C1q-C is a crucial component of the complement system, playing a significant role in the immune response by recognizing and binding to pathogens and apoptotic cells. C1q-C activates the classical complement pathway, which enhances opsonization and clearance of immune complexes. Understanding C1q-C function is vital for elucidating mechanisms of immune regulation and potential therapeutic targets in autoimmune diseases. Researchers worldwide rely on C1q-C monoclonal antibodies to investigate complement system activation and regulation. C1q-C monoclonal antibodies enable precise detection and quantification of C1q-C in various experimental settings. The exceptional quality and reliability of Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing scientific understanding of immune system function and disease mechanisms.